Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMifepristone (RU-486 ®) as a Schedule IV Controlled Drug—Implications for a Misleading Drug Policy on Women's Health Care.AuthorsHsieh, Yi-Ping; Wang, Yun-Ju; Feng, Ling-Yi; Wu, Li-Tzy; Li, Jih-HengPublicationInternational Journal of Environmental Research & Public Health, 2022, Vol 19, Issue 14, p8363ISSN1661-7827Publication typeArticleDOI10.3390/ijerph19148363